During the past decade, UMass Memorial Medical Center conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 61 clinical trials were completed, i.e. on average, 68.5% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 34 clinical trials were completed. i.e. 81% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMass Memorial Medical Center" #1 sponsor was "University of Massachusetts, Worcester" with 21 trials, followed by "Shire" with 9 trials sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored and "GOG Foundation" with 5 trials sponsored. Other sponsors include 116 different institutions and companies that sponsored additional 96 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMass Memorial Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator. Other collaborators include 150 different institutions and companies that were collaborators in the rest 124 trials.

According to Clinical.Site data, the most researched conditions in "UMass Memorial Medical Center" are "Crohn's Disease" (8 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (6 trials), "Ovarian Endometrioid Adenocarcinoma" (6 trials), "Ovarian Seromucinous Carcinoma" (6 trials) and "Ovarian Serous Adenocarcinoma" (6 trials). Many other conditions were trialed in "UMass Memorial Medical Center" in a lesser frequency.

Most popular intervention types in "UMass Memorial Medical Center" are "Drug" (96 trials), "Other" (33 trials), "Biological" (25 trials), "Device" (24 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Paclitaxel" (15 trials), "Carboplatin" (14 trials), "Quality-of-Life Assessment" (11 trials) and "Bevacizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "UMass Memorial Medical Center" are 144 trials for "All" genders, 21 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "UMass Memorial Medical Center". 2 are not yet recruiting, 24 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 94 completed trials in UMass Memorial Medical Center, 1 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in UMass Memorial Medical Center, 14 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 27 trials that are defined as “Not Applicable".